BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30
• 31

• Press Releases

  RxSight, Inc. to Report Third Quarter 2025 Financial Results on November 5, 2025

  October 22, 2025

   · 

  1 min read
• Press Releases

  PacBio to Report Third Quarter 2025 Financial Results on November 5, 2025

  October 22, 2025

   · 

  1 min read
• Press Releases

  OPKO Health to Report Third Quarter 2025 Financial Results on October 29

  October 22, 2025

   · 

  1 min read
• Press Releases

  Ventyx Biosciences Announces Positive Topline Results from Phase 2 Study of VTX3232 in Participants with Obesity and Cardiovascular Risk Factors

  October 22, 2025

   · 

  11 min read
• Press Releases

  Arvinas to Present Preclinical Data for ARV-806, a PROTAC KRAS G12D Degrader, at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

  October 22, 2025

   · 

  4 min read
• Press Releases

  Telix Doses First Patient in SOLACE Trial for Metastatic Bone Pain

  October 22, 2025

   · 

  8 min read
• Press Releases

  Invenra Inc. and Xcellon Biologics Announce Collaboration to Advance Bispecific and Trispecific Antibody-Drug Conjugate (ADC) Development

  October 22, 2025

   · 

  4 min read
• Press Releases

  Aurigene Oncology to Showcase Innovative A-PROX Platform at the AACR-NCI-EORTC International Conference 2025

  October 22, 2025

   · 

  4 min read
• Press Releases

  I-Mab To Present Positive Updated Givastomig Monotherapy Data at 2025 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference on October 23, 2025

  October 22, 2025

   · 

  10 min read
• Press Releases

  Revolution Medicines to Present Updated Elironrasib Safety and Efficacy Data in Patients with KRAS G12C Non-Small Cell Lung Cancer Following Treatment with a KRAS(OFF) G12C Inhibitor

  October 22, 2025

   · 

  7 min read